The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Not showing here yet;
https://mobile.twitter.com/OpenOrphan/status/1435122038398722050
https://audioboom.com/posts/7936560-alan-green-on-open-orphan-aquis-ananda-developments
Was thinking the same, started looking in again recently and only skimming over a few posts.
Seem you get rid of one lot, then another appear, wait for the "take over coming", "rns logged" then you'll have a full house.
Still looks like a kindergarten play area with the bickering.
Good luck all genuine holders, you know who you are.
https://www.ii.co.uk/analysis-commentary/novacyt-qa-hear-latest-covid-testing-firm-ii521157
If you want to watch, this should work
https://presentations.investormeetcompany.com/investor-meet-company/NOVACYT-S-A-Investor-Meeting?bmid=a9d61e8a5021
Movers of Wednesday 18 August 2021 https://www.**********.co.uk/articles/movers-of-wednesday-18-august-2021--4811893
That's funny as I almost posted these this morning
https://m.youtube.com/watch?v=dQw4w9WgXcQ
https://m.youtube.com/watch?v=vjD3EVC1-zU
I know way back there were some here that loved a chart ; )
Think it's about 5 minutes in
https://youtu.be/eYQRcFRXQgs
https://www.**********.co.uk/articles/novacyt-sees-1h21-revenue-jump-by-over-50--3bb7534
Thanks kaeren, I also asked Mandy the question as I couldnt see it on their page, only by link;
https://mobile.twitter.com/NovacytGroup/status/1427691704556027905
Clinical diagnostics group Novacyt (NCYT) announced a half year update in advance of its investor meeting today, showing that if nothing else, it can make good money. This is hardly surprising given the Government backed scamdemic of forced testing with the rip off pricing holiday makers are currently facing. Unaudited revenue for the first half of 2021 increased over 50% to £94.7 million, compared to £63.3 million for the first half of 2020. Of this total revenue, £54 million came from a mixture of overseas sales and a growing UK private testing market, leading to non-DHSC revenue growing 20% year-on-year. Novacyt’s Primerdesign has been awarded a new contract under the PHE National Microbiology Framework, effective immediately, for the supply of PROmate® COVID-19 tests to the NHS. One presumes that this contract was won after an extensive and fair tendering process. The contract is valued at up to £4.7m and will last until 31 March 2022. There are no minimum purchase levels as part of this contract. Separately, there is no further update to the announcement on 22 June 2021 in relation to the company's second supply contract with the DHSC which is in dispute.
The stock market is a device for transferring money from the impatient to the patient. - Warren Buffett verse10 chapter 12.